AC Immune SA (ACIU)
3.00
+0.16
(+5.63%)
USD |
NASDAQ |
Nov 01, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
AC Immune Total Liabilities (Quarterly): 126.94M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 126.94M |
| March 31, 2024 | 25.05M |
| December 31, 2023 | 26.40M |
| September 30, 2023 | 18.93M |
| June 30, 2023 | 18.79M |
| March 31, 2023 | 17.75M |
| December 31, 2022 | 18.28M |
| September 30, 2022 | 15.90M |
| June 30, 2022 | 14.64M |
| March 31, 2022 | 23.17M |
| December 31, 2021 | 32.23M |
| September 30, 2021 | 25.87M |
| June 30, 2021 | 23.68M |
| March 31, 2021 | 21.81M |
| December 31, 2020 | 26.63M |
| September 30, 2020 | 25.41M |
| June 30, 2020 | 23.55M |
| March 31, 2020 | 23.57M |
| Date | Value |
|---|---|
| December 31, 2019 | 27.67M |
| September 30, 2019 | 23.17M |
| June 30, 2019 | 23.48M |
| March 31, 2019 | 71.34M |
| December 31, 2018 | 19.23M |
| September 30, 2018 | 17.07M |
| June 30, 2018 | 17.20M |
| March 31, 2018 | 14.88M |
| December 31, 2017 | 15.58M |
| September 30, 2017 | 13.15M |
| June 30, 2017 | 10.88M |
| March 31, 2017 | 11.54M |
| December 31, 2016 | 13.48M |
| September 30, 2016 | 14.98M |
| June 30, 2016 | 13.00M |
| March 31, 2016 | 9.187M |
| December 31, 2015 | 8.992M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.64M
Minimum
Jun 2022
126.94M
Maximum
Jun 2024
28.22M
Average
23.57M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
| CRISPR Therapeutics AG | 358.90M |
| Addex Therapeutics Ltd | 1.164M |
| NLS Pharmaceutics Ltd | 10.46M |
| Molecular Partners AG | 16.74M |
| MoonLake Immunotherapeutics | 14.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.24M |
| Shareholders Equity (Quarterly) | 137.30M |
| Current Ratio | 1.796 |